TY - JOUR
T1 - Optimizing therapy in patients with pancolitis
AU - Cuffari, Carmen
AU - Present, Daniel H.
AU - Bayless, Theodore M.
AU - Lichtenstein, Gary R.
PY - 2005/10
Y1 - 2005/10
N2 - Pancolitis affects approximately 20% to 40% of the total ulcerative colitis population and remains a therapeutic challenge for clinicians. Practitioners must focus on pancolitis when evaluating a patient for ulcerative colitis, because pancolitis is associated with more severe and fulminant disease and a higher rate of colorectal cancer and colectomy. It is imperative for clinicians to be knowledgeable in the clinical course, medications, and appropriate manner to induce and maintain clinical remission to prevent serious sequelae of the disease. The purpose of this article is to provide a review of the treatment of pancolitis for general gastroenterologists, because medical management decisions have life-long effects for this subgroup of patients.
AB - Pancolitis affects approximately 20% to 40% of the total ulcerative colitis population and remains a therapeutic challenge for clinicians. Practitioners must focus on pancolitis when evaluating a patient for ulcerative colitis, because pancolitis is associated with more severe and fulminant disease and a higher rate of colorectal cancer and colectomy. It is imperative for clinicians to be knowledgeable in the clinical course, medications, and appropriate manner to induce and maintain clinical remission to prevent serious sequelae of the disease. The purpose of this article is to provide a review of the treatment of pancolitis for general gastroenterologists, because medical management decisions have life-long effects for this subgroup of patients.
KW - Pancolitis
KW - Ulcerative colitis
UR - http://www.scopus.com/inward/record.url?scp=26444453945&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=26444453945&partnerID=8YFLogxK
U2 - 10.1097/01.mib.0000179469.86500.ac
DO - 10.1097/01.mib.0000179469.86500.ac
M3 - Review article
C2 - 16189424
AN - SCOPUS:26444453945
SN - 1078-0998
VL - 11
SP - 937
EP - 946
JO - Inflammatory bowel diseases
JF - Inflammatory bowel diseases
IS - 10
ER -